p53 tumour-suppressor gene mutations are mainly localised on exon 7 in human primary and metastatic prostate cancer
1996

p53 Gene Mutations in Prostate Cancer

Sample size: 45 publication Evidence: moderate

Author Information

Author(s): R Dahiya, G Deng, KM-K Chen, RM Chui, PC Haughney, P Narayan

Primary Institution: University of California San Francisco and Veterans' Affairs Medical Center

Hypothesis

The study aims to characterize p53 mutations in primary and metastatic human prostate cancer specimens.

Conclusion

p53 mutations were found exclusively in exon 7 of the gene, with 8% in primary prostate cancers and 20% in metastatic cancers.

Supporting Evidence

  • Mutations were found in 2 out of 25 primary prostate cancers (8%) and 4 out of 20 metastatic cancers (20%).
  • Mutations were observed exclusively in exon 7 and not in exons 4, 5, 6, 8, or 9.
  • Nuclear accumulation of p53 protein correlated with the degree of metastasis in prostatic cancer.

Takeaway

Scientists looked at prostate cancer samples to see if there were changes in a gene called p53, which helps stop cancer, and found that most changes happened in a specific part of the gene.

Methodology

The study used hot-start PCR-SSCP analysis and sequencing to examine p53 mutations in prostate cancer specimens.

Limitations

The study only analyzed a limited number of samples, which may not represent all possible mutations in the p53 gene.

Participant Demographics

The study included 25 primary prostate cancer specimens and 20 metastatic lymph node specimens.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication